SCHEMBL27409581

SCHEMBL27409581

CC(C)CCOC(C)CCn1cc(CNC(=O)CCCC#Cc2cnc([S+](C)[O-])nc2)nn1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GLS O94925 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27409884 0.88 GLS (0.33) GLS
SCHEMBL27411159 0.88 GLS (0.32) GLS
SCHEMBL27411266 0.81 GLS (0.31) GLS
SCHEMBL27409833 0.81 CNR2 (0.34) GLS
SCHEMBL25816633 0.76 BCHE (0.33) —
SCHEMBL27409985 0.71 GBA1 (0.37) GLS
SCHEMBL25046734 0.69 FNTA (0.35) GLS
SCHEMBL26167073 0.69 CYP1A2 (0.31) —
SCHEMBL27410347 0.68 FOLH1 (0.32) —
SCHEMBL21286187 0.67 GBA1 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024123914-A1 PROCESS FOR MAKING ANTIBODY-DRUG CONJUGATES MERCK SHARP & DOHME LLC (US) 2024-06-13 — — WO disclosed
Send feedback